ESR1 and triple-negative breast carcinoma: Based on protein-coding gene expression profiling, breast tumors were classified into at least three major molecular subtypes: (i) estrogen receptor positive (ER+) luminal A or B, (ii) epidermal growth factor receptor 2 positive (HER2+) and (iii) triple-negative breast cancer (TNBC) lacking expression of estrogen and progesterone nuclear receptors (ER-, PR-) and human epidermal growth factor receptor 2 amplification (HER2) [2,3].